These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38003973)

  • 1. Cardiac Magnetic Resonance Left Ventricular Filling Pressure Is Associated with NT-proBNP in Patients with New Onset Heart Failure.
    Assadi H; Matthews G; Chambers B; Grafton-Clarke C; Shabi M; Plein S; Swoboda PP; Garg P
    Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003973
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac magnetic resonance left ventricular filling pressure is linked to symptoms, signs and prognosis in heart failure.
    Grafton-Clarke C; Garg P; Swift AJ; Alabed S; Thomson R; Aung N; Chambers B; Klassen J; Levelt E; Farley J; Greenwood JP; Plein S; Swoboda PP
    ESC Heart Fail; 2023 Oct; 10(5):3067-3076. PubMed ID: 37596895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications.
    Garg P; Gosling R; Swoboda P; Jones R; Rothman A; Wild JM; Kiely DG; Condliffe R; Alabed S; Swift AJ
    Eur Heart J; 2022 Jul; 43(26):2511-2522. PubMed ID: 35512290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic multimodal non-invasive assessment of cardiac performance in patients with heart failure.
    Kim MJ; Cho JS; Lee K; Kwon W; Ohn C; Lee M; Kim DW; Kim TS; Park MW
    ESC Heart Fail; 2023 Aug; 10(4):2567-2576. PubMed ID: 37312276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure.
    Dini FL; Whalley G; Poppe K; Fontanive P; Rosa GM; Doughty RN; Di Bello V
    Clin Cardiol; 2009 Dec; 32(12):711-7. PubMed ID: 20027664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.
    Choi EY; Bahrami H; Wu CO; Greenland P; Cushman M; Daniels LB; Almeida AL; Yoneyama K; Opdahl A; Jain A; Criqui MH; Siscovick D; Darwin C; Maisel A; Bluemke DA; Lima JA
    Circ Heart Fail; 2012 Nov; 5(6):727-34. PubMed ID: 23032197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Left Ventricular Characteristics Assessed by Cardiac Magnetic Resonance Imaging and Cardiovascular Biomarkers Related to Kidney Transplantation.
    Prasad GVR; Yan AT; Nash MM; Kim SJ; Wald R; Wald R; Lok C; Gunaratnam L; Karur GR; Kirpalani A; Connelly PW
    Can J Kidney Health Dis; 2018; 5():2054358118809974. PubMed ID: 30542623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation.
    Westhoff-Bleck M; Kornau F; Haghikia A; Horke A; Bertram H; Treptau J; Widder J; Bauersachs J; Brehm MU
    Can J Cardiol; 2016 Oct; 32(10):1247.e29-1247.e36. PubMed ID: 26927857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy.
    Abbasi SA; Shah RV; McNulty SE; Hernandez AF; Semigran MJ; Lewis GD; Jerosch-Herold M; Kim RJ; Redfield MM; Kwong RY
    PLoS One; 2016; 11(11):e0164914. PubMed ID: 27812147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
    Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal changes of left ventricular filling pressure and N-terminal pro-brain natriuretic peptide on chronic hemodialysis.
    Kim YK; Shin SJ; Ihm SH; Park CS; Kim HY; Hong TY; Song HC; Yang CW; Kim YS; Choi EJ
    Clin Nephrol; 2010 Sep; 74(3):190-7. PubMed ID: 20860903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma NT-proBNP levels associated with cardiac structural abnormalities in asymptomatic health examinees with preserved ejection fraction: a retrospective cross-sectional study.
    Nah EH; Kim SY; Cho S; Kim S; Cho HI
    BMJ Open; 2019 Apr; 9(4):e026030. PubMed ID: 31005928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of sST2 and NT-proBNP at admission in heart failure with preserved, mid-ranged and reduced ejection fraction.
    Huang A; Qi X; Hou W; Qi Y; Zhao N; Liu K
    Acta Cardiol; 2018 Feb; 73(1):41-48. PubMed ID: 28944719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation.
    Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV;
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
    Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
    ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
    Hamatani Y; Iguchi M; Ueno K; Aono Y; Esato M; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Morita S; Akao M
    Heart; 2021 May; 107(9):705-712. PubMed ID: 33219109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
    Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV
    Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.